| Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis J Allotey, S Fernandez, M Bonet, E Stallings, M Yap, T Kew, D Zhou, ... bmj 370, 2020 | 2501 | 2020 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1540 | 2021 |
| A systematic review of rapid diagnostic tests for the detection of tuberculosis infection J Dinnes, J Deeks, H Kunst, A Gibson, E Cummins, N Waugh, ... Health technology assessment 11 (3), 2007 | 768 | 2007 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 484* | 2021 |
| Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR-and XDR-TB: a multicentre study SE Borisov, K Dheda, M Enwerem, RR Leyet, L D'Ambrosio, R Centis, ... European Respiratory Journal 49 (5), 2017 | 367 | 2017 |
| Accuracy of information on apparently credible websites: survey of five common health topics H Kunst, D Groot, PM Latthe, M Latthe, KS Khan Bmj 324 (7337), 581-582, 2002 | 366 | 2002 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 317 | 2021 |
| Worldwide effects of coronavirus disease pandemic on tuberculosis services, January–April 2020 GB Migliori, PM Thong, O Akkerman, JW Alffenaar, F Álvarez-Navascués, ... Emerging infectious diseases 26 (11), 2709, 2020 | 226 | 2020 |
| MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network GB Migliori, S Tiberi, A Zumla, E Petersen, JM Chakaya, C Wejse, ... International Journal of Infectious Diseases 92, S15-S25, 2020 | 221 | 2020 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 219 | 2022 |
| Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study I Abubakar, F Drobniewski, J Southern, AJ Sitch, C Jackson, M Lipman, ... The Lancet Infectious Diseases 18 (10), 1077-1087, 2018 | 189 | 2018 |
| Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report S Borisov, E Danila, A Maryandyshev, M Dalcolmo, S Miliauskas, L Kuksa, ... European Respiratory Journal 54 (6), 2019 | 187 | 2019 |
| Direct whole-genome sequencing of sputum accurately identifies drug-resistant Mycobacterium tuberculosis faster than MGIT culture sequencing RM Doyle, C Burgess, R Williams, R Gorton, H Booth, J Brown, JM Bryant, ... Journal of Clinical Microbiology 56 (8), 10.1128/jcm. 00666-18, 2018 | 181 | 2018 |
| Maternal and perinatal mortality and morbidity associated with tuberculosis during pregnancy and the postpartum period: a systematic review and meta‐analysis S Sobhy, ZOE Babiker, J Zamora, KS Khan, H Kunst BJOG: An International Journal of Obstetrics & Gynaecology 124 (5), 727-733, 2017 | 154 | 2017 |
| Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis H Kunst, M Wickremasinghe, A Wells, R Wilson European Respiratory Journal 28 (2), 352-357, 2006 | 142 | 2006 |
| SARS-CoV-2 positivity in offspring and timing of mother-to-child transmission: living systematic review and meta-analysis J Allotey, S Chatterjee, T Kew, A Gaetano, E Stallings, ... Bmj 376, 2022 | 136 | 2022 |
| Tuberculosis incidence correlates with sunshine: an ecological 28-year time series study GCKW Koh, G Hawthorne, AM Turner, H Kunst, M Dedicoat PloS one 8 (3), e57752, 2013 | 135 | 2013 |
| Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR-and XDR-TB S Tiberi, MC Payen, G Sotgiu, L D'Ambrosio, VA Guizado, JW Alffenaar, ... European Respiratory Journal 47 (4), 1235-1243, 2016 | 122 | 2016 |
| Parasitic infections of the lung: a guide for the respiratory physician H Kunst, D Mack, OM Kon, AK Banerjee, P Chiodini, A Grant Thorax 66 (6), 528-536, 2011 | 117 | 2011 |
| Multidrug-resistant tuberculosis in Europe, 2010–2011 G Guenther, F Van Leth, S Alexandru, N Altet, K Avsar, D Bang, R Barbuta, ... Emerging infectious diseases 21 (3), 409, 2015 | 114 | 2015 |
